Clinical Trial Update: A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of remibrutinib using magnetic resonance imaging in relapsing-remitting, secondary progressive, and primary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Remibrutinib (remibrutinib)

Snippet

Sponsor: Moein Amin | Conditions: Multiple Sclerosis (MS) - Relapsing-remitting, Multiple Sclerosis (MS) Secondary Progressive | Phase 2 | Status: NOT_YET_RECRUITING